Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Brazília1/2. fázis

Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor.

A legfontosabb adatok

Ki végzi
São Paulo State University
Hol
São Paulo (Brazília)A helyszín megnézése
Azonosító
Állapot
Toboroz
Fázis
1/2. fázis
Résztvevők
36 fő, tervezett
Kezdés
2026. jan. 15.
Várható befejezés
2027. jan.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Dual-site repetitive transcranial magnetic stimulation (rTMS) of the supplementary motor area and cerebellum
  • Transcranial Magnetic Stimulation Sham
A regiszteradat frissítve
2026. január 21.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with essential tremor that has not been controlled well enough by standard medicines. It tests magnetic brain stimulation (rTMS) against a sham (fake) stimulation.

Életkor
18 to 80 years
Nem
Men and women
A betegség stádiuma
Essential tremor with a score greater than 2 on items 5 or 6 of the Fahn-Tolosa-Marin Tremor Rating Scale, despite optimized medical therapy.
Korábbi kezelés
Must have already tried both propranolol and primidone at the highest doses they could tolerate, without enough tremor control.

A részvétel fő kizáró okai

  • Pregnancy or breastfeeding
  • An implanted deep brain stimulation (DBS) system or a cardiac pacemaker
  • Metal implants in the body that rule out rTMS
  • Epilepsy not well controlled, meaning seizure-free for less than 5 years
  • Unstable or untreated psychiatric disorders, or uncontrolled medical conditions such as diabetes, high blood pressure, lung or heart disease

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Male or female participants, aged 18 to 80 years; women of childbearing potential must not be pregnant
  • Diagnosis of Essential Tremor with a score greater than 2 on items 5 or 6 of the Fahn-Tolosa-Marin Tremor Rating Scale despite optimized medical therapy
  • Medication-refractory tremor, defined as prior use of both first-line medications (propranolol and primidone) at maximally tolerated doses without adequate tremor control
  • Ability to provide written informed consent in accordance with institutional policies
  • Ability to comply with all study procedures and follow-up assessments as defined by the study protocol

Ki nem vehet részt

  • Concomitant participation in another investigational drug or device study
  • Presence of metallic implants in any part of the body that are contraindicated for rTMS
  • Unstable or untreated psychiatric disorders
  • Uncontrolled medical conditions, including but not limited to uncontrolled diabetes mellitus, hypertension, symptomatic pulmonary disease, or symptomatic cardiac disease
  • History of epilepsy not adequately controlled, defined as seizure-free for less than 5 years
  • Presence of a cardiac pacemaker
  • Inability to provide informed consent
  • Pregnancy or breastfeeding
  • Presence of an implanted deep brain stimulation (DBS) system

Ez a vizsgálat jelenleg itt érhető el: Brazília.

  • Sao Paulo UniversitySão Paulo, BrazíliaContact: ANANDA CAROLINA MORAES DE FALCONERésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Essential tremor is a common movement disorder that causes involuntary shaking, mainly during voluntary actions such as writing or holding objects. Recent research suggests that essential tremor is not caused by a single brain area, but by abnormal activity within a network that includes the cerebellum and motor areas of the brain. However, most non-invasive brain stimulation studies to date have targeted only one brain region and have shown inconsistent clinical benefits.

A teljes eredeti leírásKevesebb

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effects of a dual-site transcranial magnetic stimulation (rTMS) protocol targeting the supplementary motor area (SMA) and the cerebellum in patients with essential tremor that does not respond adequately to standard medications. The study is based on previous pilot data showing meaningful tremor reduction using combined stimulation of these two brain regions.

Participants will receive five sessions of rTMS, consisting of low-frequency stimulation over the SMA followed by high-frequency stimulation over the cerebellum. The main hypothesis is that this combined approach will lead to an immediate and sustained improvement in action tremor of the dominant upper limb, measured up to four weeks after treatment. Secondary outcomes include quality of life, safety, side effects, and changes in brain excitability associated with tremor improvement.

A vizsgálat 2 csoportja

  • Dual-site rTMS over SMA (1 Hz, 110% RMT) and cerebellum (10 Hz, 90% RMT) for 5 days.A vizsgált kezelés

    Sham stimulation over SMA and cerebellum using inactive coil with sound simulation for 5 days.

    Kezelés: Dual-site repetitive transcranial magnetic stimulation (rTMS) of the supplementary motor area and cerebellum

  • ShamSzínlelt kezelés, összehasonlításként

    The sham intervention replicates the anatomical targeting, sequence, session duration, and acoustic characteristics of the active dual-site rTMS protocol without delivering an effective magnetic field. An inactive coil is positioned over the same supplementary motor area and cerebellar targets, while sound simulation is used to mimic active stimulation, ensuring maintenance of blinding and comparability with the active intervention.

    Kezelés: Transcranial Magnetic Stimulation Sham

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. január 21.